We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$484M
AUM Growth
+$33.4M
Cap. Flow
+$5.94M
Cap. Flow %
1.23%
Top 10 Hldgs %
35.68%
Holding
242
New
81
Increased
34
Reduced
44
Closed
12

Top Buys

Rank Stock Value
1
BFAM icon
Bright Horizons
BFAM
+$12.3M
2
BR icon
Broadridge
BR
+$12.1M
3
THS
Treehouse Foods
THS
+$11.5M
4
CHKP icon
Check Point Software Technologies
CHKP
+$11.2M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.04M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$13.6M
2
PXD
Pioneer Natural Resource Co.
PXD
+$9.4M
3
GE icon
GE Aerospace
GE
+$9.22M
4
AIG icon
American International
AIG
+$8.23M
5
CFG icon
Citizens Financial Group
CFG
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Financials 18.99%
3 Healthcare 18.33%
4 Consumer Staples 11.91%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
26
SLB Ltd
SLB
$75B
$8.11M 1.67%
103,846
-47
-0% -$3.84K
CVX icon
27
Chevron
CVX
$366B
$7.75M 1.6%
72,206
-1,303
-2% -$146K
GS icon
28
Goldman Sachs
GS
$303B
$7.65M 1.58%
33,307
-11,078
-25% -$2.67M
ENOV icon
29
Enovis
ENOV
$1.53B
$7.51M 1.55%
111,087
– –
AFL icon
30
Aflac
AFL
$62.6B
$7.28M 1.5%
200,970
-1,400
-0.7% -$49.6K
ETN icon
31
Eaton
ETN
$174B
$5.82M 1.2%
78,430
– –
ALKS icon
32
Alkermes
ALKS
$8.25B
$5.52M 1.14%
94,400
+49,400
+110% +$2.8M
GOOG icon
33
Alphabet (Google) Class C
GOOG
$4.32T
$5.47M 1.13%
131,940
-2,080
-2% -$85.3K
JPM icon
34
JPMorgan Chase
JPM
$950B
$5.32M 1.1%
60,557
+7
+0% +$618
CSCO icon
35
Cisco
CSCO
$479B
$5.25M 1.08%
155,371
+7,275
+5% +$236K
AMAT icon
36
Applied Materials
AMAT
$428B
$5.07M 1.05%
130,320
-3,800
-3% -$136K
GILD icon
37
Gilead Sciences
GILD
$165B
$4.6M 0.95%
67,755
+28,305
+72% +$1.99M
EW icon
38
Edwards Lifesciences
EW
$51.7B
$4.38M 0.91%
139,800
+120,000
+606% +$3.76M
PG icon
39
Procter & Gamble
PG
$339B
$3.75M 0.77%
41,683
-224
-0.5% -$19.9K
AGN
40
DELISTED
Allergan plc
AGN
$2.56M 0.53%
10,721
+1,747
+19% +$407K
MMM icon
41
3M
MMM
$94.3B
$2.52M 0.52%
15,718
-1,076
-6% -$165K
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$126B
$2.31M 0.48%
21,087
+2
+0% +$176
GE icon
43
GE Aerospace
GE
$384B
$2.3M 0.48%
16,129
-63,711
-80% -$9.22M
ABBV icon
44
AbbVie
ABBV
$435B
$1.74M 0.36%
26,695
-350
-1% -$22K
XOM icon
45
ExxonMobil
XOM
$634B
$1.57M 0.32%
19,118
-600
-3% -$50.1K
ALB icon
46
Albemarle
ALB
$15.5B
$1.52M 0.31%
14,358
– –
RDS.A
47
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.45M 0.3%
28,045
-504
-2% -$26.3K
WFC.PRL icon
48
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.29M 0.27%
+1,045
New +$1.27M
CYS.PRB
49
DELISTED
CYS Investments, Inc.
CYS.PRB
$1.23M 0.25%
52,350
+9,900
+23% +$231K
QCOM icon
50
Qualcomm
QCOM
$176B
$1.21M 0.25%
21,058
-235,090
-92% -$13.6M
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return

Kelly Lawrence W & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Kelly Lawrence W & Associates held 242 positions worth $484M, up 7.4% from $451M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates's Q1 2017 filing shows 81 new, 34 increased, 44 reduced and 12 closed positions. Its largest new stake was Bright Horizons: 175,040 shares worth $12.7M. The largest sale was Qualcomm, an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Kelly Lawrence W & Associates's largest Q1 2017 buy was Bright Horizons: 175,040 shares worth $12.7M.
  • Kelly Lawrence W & Associates added most to Regeneron Pharmaceuticals in Q1 2017, an estimated $9.04M increase.
  • Kelly Lawrence W & Associates's biggest Q1 2017 reduction was Qualcomm, cutting an estimated $13.6M.
  • Kelly Lawrence W & Associates fully exited Flowserve in Q1 2017, selling an estimated $2.21M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $484M portfolio in Q1 2017.
  • Kelly Lawrence W & Associates opened 81 new positions and closed 12 in Q1 2017.
  • Kelly Lawrence W & Associates's portfolio value rose 7.4% quarter-over-quarter to $484M.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2017, filed 15 May 2017.